Metrorrhagia: Clinical Trials

9 trials for Metrorrhagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 unknown, 1 withdrawn. 9 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Recruiting 1, Unknown 1, Withdrawn 1
Phase 11Completed 1

Follow Metrorrhagia: new trials by email Literature Review of Metrorrhagia trials Research Report on Metrorrhagia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Transdermal Ethinyl Estradiol/Norelgestromin Patch, Placebo Patch - Menstruation Disturbances, Metrorrhagia
Phase 2RecruitingChulalongkorn University402025-07-292025-12-10
D-chiro-inositol and AUB
D-chiro-inositol and lactalbumin (high dose), D-chiro-inositol and lactalbumin (low dose) - Abnormal Uterine Bleeding
Phase 2UnknownUniversity Of Perugia202024-06-012024-05-03
Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study
Etonogestrel 68mg implant - Abnormal Uterine Bleeding, Dysmenorrhea
Phase 2WithdrawnSaskatchewan Health Authority - Regina Area2022-07-012025-11-25
Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome
Kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine, Gong Xue Ning capsules - Dysfunctional Uterine Bleeding
Phase 2CompletedChildren's Hospital of Fudan University1602020-09-022022-08-03
The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding
Metraplant-E levonorgestrel-releasing intrauterine device - Dysfunctional Uterine Bleeding
Phase 1 / Phase 2CompletedAin Shams Maternity Hospital612014-06-012016-03-14
Genistein and Endometrial Hyperplasia
Genivis, Norethisterone Acetate, placebo - Endometrial Hyperplasia
Phase 2CompletedUniversity of Messina592007-01-012008-12-19
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
DR-1031, Seasonale®, Portia® - Breakthrough Bleeding
Phase 2CompletedDuramed Research5672006-10-012013-07-26
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
Norgestimate/Ethinyl Estradiol tablet - Metrorrhagia
Phase 2CompletedMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.612003-11-012011-03-04
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
norelgestromin/ethinyl estradiol - Metrorrhagia
Phase 2CompletedMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.2392011-07-01

Narrower conditions

Contraception Behavior (1)  ·  Dysmenorrhea (1)  ·  Endometrial Hyperplasia (1)  ·  Menstruation Disturbances (1)  ·  Pain (1)  ·  Uterine Hemorrhage (1)

Broader conditions

Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Genital Diseases (9)  ·  Genital Diseases, Female (9)  ·  Hemorrhage (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Urogenital Diseases (9)  ·  Uterine Diseases (9)  ·  Uterine Hemorrhage (8)  ·  Behavior (1)  ·  Menstruation Disturbances (1)  ·  Neurologic Manifestations (1)  ·  Pelvic Pain (1)  ·  Reproductive Behavior (1)

Interventions

Ethinyl Estradiol (2)  ·  Drug Implants (1)  ·  Ethinyl Estradiol-Norgestrel Combination (1)  ·  Lactalbumin (1)  ·  Moxifloxacin (1)  ·  Mutagenesis, Insertional (1)  ·  Norethindrone Acetate (1)  ·  Seasonale (1)  ·  etonogestrel (1)  ·  norelgestromin (1)

Sponsors

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. (2)  ·  Ain Shams Maternity Hospital (1)  ·  Children's Hospital of Fudan University (1)  ·  Chulalongkorn University (1)  ·  Duramed Research (1)  ·  Saskatchewan Health Authority - Regina Area (1)  ·  University Of Perugia (1)  ·  University of Messina (1)

Countries

Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Italy (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Mohamed Azzam, MD (1)  ·  Rosario D'Anna, prof. (1)  ·  Sarah N Smith, MD (1)

Results publications

PMID 12466350, PMID 15932834, PMID 15950671